Surgical Science Sweden AB (FRA:4P41) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4P41 Surgical Science Sweden AB FRA:4P41
82 GF Score
Price €2.74
GF Value €13.97
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:4P41
82GF Score
Surgical Science Sweden AB FRA:4P41
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Surgical Science Sweden AB (FRA:4P41) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of €2.74 is trading 80.4% below its estimated GF Value™ of €13.97. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for FRA:4P41:

  • Dividends Received:
  • GF Value™: €13.97 vs. price of €2.74 (80.4% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the FRA:4P41 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgical Science Sweden AB Business Description

Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for FRA:4P41

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price
€13.97
GF Value